BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Gatehouse Bio

Gatehouse Bio logo

Founded
2016
Geography
United States of America based
Funding
$7.945 M

Gatehouse Bio’s ‘sRNAlytics platform’ identifies novel small RNA (sRNA) signatures and illuminates molecular pathways correlated to and potentially driving disease. “Our annotation library of over 1.4M small RNA features coupled with our biology-directed machine learning algorithms enable us to see signal where others have only seen noise,” said Dr. David W. Salzman, CEO and Chief Scientist, Gatehouse Bio.


sRNA next-gen therapeutics

Technologies

AI Companies (Drug Discovery)   Gene Therapy Startups   RNA-focused Startups  


Posts Mentioning This Company

R&D Platform

Our sRNA platform lets us act on opportunities everywhere.
In the dark area of the genome,
In the unseen connection of disease pathways,
In the novel uses of existing compounds.


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet